Literature DB >> 18067562

Physical therapy in the management of women with chronic pelvic pain.

M L L S Montenegro1, E C L M Vasconcelos, F J Candido Dos Reis, A A Nogueira, O B Poli-Neto.   

Abstract

OBJECTIVES: Chronic pelvic pain (CPP) is defined as lower abdominal pain lasting for at least 6 months, which occurs continuously or intermittently and is not associated exclusively with menstruation or intercourse. CPP is a highly prevalent debilitating disease with negative impact on the quality of life and productivity of women. The dilemma regarding the management of CPP continues to frustrate the health professionals, partly because its physiopathology is poorly understood. Consequently, the treatment of this condition is often unsatisfactory and limited to temporary symptom relief. In the present review, we discuss characteristics of the clinical history and physical examination associated with musculoskeletal involvement in women with CPP and possible treatments, especially in the area of physiotherapy.
METHODS: We evaluated data available in PubMed (1984-2006) and surveyed the reference list. Three reviewers analysed the data independently, considering a study to be of high quality if it had at least three of the following characteristics: prospective design, valid measurement instruments, and adequate sample estimate and response rate. Other studies such as retrospective investigations, reviews and expert opinions were also considered, but with decreasing emphasis.
RESULTS: There are evidences of musculoskeletal system disorders in most women with CPP. These musculoskeletal disorders can be the primary cause of CPP or postural changes and pelvic muscle contractures secondary to CPP.
CONCLUSIONS: Synchronised intervention by physicians and physiotherapists is becoming increasingly more necessary both in terms of a more refined diagnosis of the clinical situation and of the institution of effective and lasting treatment.

Entities:  

Mesh:

Year:  2007        PMID: 18067562     DOI: 10.1111/j.1742-1241.2007.01530.x

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  7 in total

1.  A directional preference approach for chronic pelvic pain, bladder dysfunction and concurrent musculoskeletal symptoms: a case series.

Authors:  Christine Hughes; Stephen May
Journal:  J Man Manip Ther       Date:  2019-11-08

Review 2.  Botulinum neurotoxin type A injection of the pelvic floor muscle in pain due to spasticity: a review of the current literature.

Authors:  Alka A Bhide; Federica Puccini; Vik Khullar; Suzy Elneil; G Alessandro Digesu
Journal:  Int Urogynecol J       Date:  2013-01-12       Impact factor: 2.894

Review 3.  Recognizing myofascial pelvic pain in the female patient with chronic pelvic pain.

Authors:  Elizabeth A Pastore; Wendy B Katzman
Journal:  J Obstet Gynecol Neonatal Nurs       Date:  2012-08-03

4.  Mucosal versus muscle pain sensitivity in provoked vestibulodynia.

Authors:  Kathryn Witzeman; Ruby Hn Nguyen; Alisa Eanes; Sawsan As-Sanie; Denniz Zolnoun
Journal:  J Pain Res       Date:  2015-08-12       Impact factor: 3.133

5.  Pelvic floor rehabilitation in the treatment of women with dyspareunia: a randomized controlled clinical trial.

Authors:  Fariba Ghaderi; Parvin Bastani; Sakineh Hajebrahimi; Mohammad Asghari Jafarabadi; Bary Berghmans
Journal:  Int Urogynecol J       Date:  2019-07-08       Impact factor: 2.894

6.  Effect of neurogenic acupoint cupping on high sensitive C-reactive protein and pain perception in female chronic pelvic pain: A randomized controlled trial.

Authors:  Khadiga S Abdulaziz; Rehab Tareq Mohamad; Lama Saad El-Din Mahmoud; Tarek Abdel Azim Ramzy; Doaa A Osman
Journal:  J Musculoskelet Neuronal Interact       Date:  2021-03-01       Impact factor: 2.041

7.  Postural changes in women with chronic pelvic pain: a case control study.

Authors:  Mary Lls Montenegro; Elaine Cl Mateus-Vasconcelos; Júlio C Rosa E Silva; Francisco J Candido Dos Reis; Antonio A Nogueira; Omero B Poli-Neto
Journal:  BMC Musculoskelet Disord       Date:  2009-07-07       Impact factor: 2.362

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.